Table 1.

Demographic characteristics and evolution of ovarian reserve markers in patients with fertility preservation before chemotherapy

Demographic characteristics and outcomes	HL patients with FP before CT
Age at diagnosis (years) (median, IQR)	24.3 (19.7, 28.1)
Body mass index (kg/m2) (median, IQR)	21.5 (19.5, 24.5)
Stage (n (%))
I	6 (6)
II	30 (29)
III	14 (13)
IV	17 (16)
Unknown	38 (36)
Basal AMH (ng/mL) (median, IQR)	2.2 (1.1, 4.3)
Basal AFC (n (%)) (median, IQR)	18 (13, 24)
Follow-up (months) (median, IQR)	33.2 (15.1, 60.9)
Last AMH (ng/mL) (median, IQR)	1.22 (0.63, 2.52)
Last—basal AMH (ng/mL) (median, IQR)	0.88 (0.15, 2.59)
Last AFC (n (%)) (median, IQR)	10 (7, 16)
Last—basal AFC (n (%)) (median, IQR)	8.5 (3.5, 14)

HL, Hodgkin lymphoma; FP, fertility preservation; CT, chemotherapy; IQR, interquartile range; BMI, body mass index; AMH, anti-Müllerian hormone; AFC, antral follicle count